Lishan Tan
- Nephrology top 5%
- Acute Kidney Injury Research 4
- Chronic Kidney Disease and Diabetes 3
- Dialysis and Renal Disease Management 3
-
- Nanoparticle-Based Drug Delivery 4
-
- Renin-Angiotensin System Studies 5
-
- Nanocluster Synthesis and Applications 4
-
- Hormonal Regulation and Hypertension 4
-
- Eicosanoids and Hypertension Pharmacology 2
In The Last Decade
Lishan Tan
25 papers receiving 455 citations
Peers
Comparison fields: 5 of 94
- Nephrology 104
- Biomaterials 76
- Geriatrics and Gerontology 14
- Developmental Neuroscience 14
- Complementary and alternative medicine 22
Countries citing papers authored by Lishan Tan
This map shows the geographic impact of Lishan Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lishan Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lishan Tan more than expected).
Fields of papers citing papers by Lishan Tan
This network shows the impact of papers produced by Lishan Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lishan Tan. The network helps show where Lishan Tan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lishan Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 19 | |
| 5 | 2021 | 40 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 22 | |
| 8 | 2020 | 8 | |
| 9 | 2019 | 29 | |
| 10 | Renal and cerebral RAS interaction contributes to diabetic kidney disease. | 2019 | 8 |
| 11 | 2019 | 57 | |
| 12 | 2018 | 8 | |
| 13 | 2018 | 35 | |
| 14 | 2017 | 30 | |
| 15 | 2017 | 4 | |
| 16 | 2017 | 14 | |
| 17 | 2017 | 26 | |
| 18 | 2016 | 12 | |
| 19 | 2016 | 8 | |
| 20 | 2007 | 35 |
About Lishan Tan
Lishan Tan is a scholar working on Nephrology, Biomaterials and Biochemistry, having authored 27 papers that have together received 457 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (5 papers), Nanocluster Synthesis and Applications (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Acute Kidney Injury Research (4 papers), Hormonal Regulation and Hypertension (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Dialysis and Renal Disease Management (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Nephrology (104 citations), Biomaterials (76 citations) and Geriatrics and Gerontology (14 citations). Lishan Tan has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Jianqiang Hu, Aiqing Li, Xiulong Deng, Mengbi Zhang, Zuying Xiong, Jiawen Li, Tao Zeng, Meng Yu, Yan Jia and Caili Huang. Their work appears in journals such as Frontiers in Physiology, Scientific Reports, Biomaterials Science, ACS Biomaterials Science & Engineering and Journal of Investigative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.